AMBIVAX Trademark

Trademark Overview

On Tuesday, June 1, 2021, a trademark application was filed for AMBIVAX with the United States Patent and Trademark Office. The USPTO has given the AMBIVAX trademark a serial number of 90746580. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, July 17, 2024. This trademark is owned by ImmunityBio, Inc.. The AMBIVAX trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations; biological preparations; pharmaceutical preparations; vaccines; immune boosters being medicinal preparations and pharmaceutical preparations; all of the aforementioned for use in the treatment and/or prevention of cancer and infectious diseases
ambivax

General Information

Serial Number90746580
Word MarkAMBIVAX
Filing DateTuesday, June 1, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements

Goods and ServicesMedicinal preparations; biological preparations; pharmaceutical preparations; vaccines; immune boosters being medicinal preparations and pharmaceutical preparations; all of the aforementioned for use in the treatment and/or prevention of cancer and infectious diseases
Pseudo MarkAM BIVAX; AMBI VAX; AMBI VACCINES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, August 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021ASSIGNED TO EXAMINER
Friday, June 4, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 9, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, November 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 9, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 21, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 21, 2022SOU EXTENSION 1 GRANTED
Thursday, July 21, 2022SOU EXTENSION 1 FILED
Wednesday, January 11, 2023SOU EXTENSION 2 GRANTED
Saturday, July 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2023SOU EXTENSION 2 FILED
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 19, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 19, 2023SOU EXTENSION 3 FILED
Wednesday, July 19, 2023SOU EXTENSION 3 GRANTED
Tuesday, January 2, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 4 FILED
Wednesday, January 24, 2024SOU EXTENSION 4 GRANTED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU EXTENSION 5 GRANTED
Wednesday, July 17, 2024SOU EXTENSION 5 FILED

Related Keywords

ambivax preparations medicinal pharmaceutical prevention diseases cancer infectious treatment boosters biological